NDUFA9 and breast cancer: reported that Aifm3 can be applied as a prognostic bio‐indicator for breast cancer patients.[48] Our research has shown that Aifm3 knockdown results in impaired neurogenesis and oxidative state of the NPCs and indicated that Aifm3 interacts with Ndufa9, a component of complex I, in the electron transport chain of the inner mitochondrial membrane, disrupts the electron transport chain and inhibits the TCA cycle, which in turn inhibits oxidative phosphorylation.